Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ACT LOVASTATIN 20 MG

LOVASTATIN : 20 MG · DIN 02248572 · TEVA CANADA LIMITED

Health Canada status: CANCELLED POST MARKET

What is ACT LOVASTATIN?

ACT LOVASTATIN 20 MG contains LOVASTATIN : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02248572, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02248572
Brand nameACT LOVASTATIN
Generic / active ingredientLOVASTATIN : 20 MG
ManufacturerTEVA CANADA LIMITED
Strength20 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeC10AA02 LOVASTATIN
AHFS class24:06.08
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date30-Jul-2025
Original market date2004-07-28 00:00:00

Is LOVASTATIN in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by AA PHARMA INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for ACT LOVASTATIN

What can be used instead?

Other Canadian products sharing ATC code C10AA02 LOVASTATIN. 2 of 35 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
LOVASTATIN20 MGTABLETAA PHARMA INCMARKETEDDIN 02220172
LOVASTATIN40 MGTABLETAA PHARMA INCMARKETEDDIN 02220180
ACT LOVASTATIN40 MGTABLETTEVA CANADA LIMITEDCANCELLED POST MARKETDIN 02248573
AVA-LOVASTATIN20 MGTABLETAVANSTRA INCCANCELLED POST MARKETDIN 02364239
AVA-LOVASTATIN40 MGTABLETAVANSTRA INCCANCELLED POST MARKETDIN 02364247
DOM-LOVASTATIN20 MGTABLETDOMINION PHARMACALCANCELLED POST MARKETDIN 02247231
DOM-LOVASTATIN40 MGTABLETDOMINION PHARMACALCANCELLED POST MARKETDIN 02247232
LOVASTATIN20 MGTABLETSANIS HEALTH INCCANCELLED POST MARKETDIN 02353229
LOVASTATIN20 MGTABLETCOBALT PHARMACEUTICALS COMPANYCANCELLED PRE MARKETDIN 02344335
LOVASTATIN40 MGTABLETSANIS HEALTH INCCANCELLED POST MARKETDIN 02353237

Who else supplies LOVASTATIN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. LOVASTATIN appears in 3 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ACT LOVASTATIN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for ACT LOVASTATIN

Health Canada Drug Product Database (DPD), DIN 02248572. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.